The Food and Drug Administration recently rejected approval of Cephalon Inc.’s newest drug Sparlon, an attention deficit/hyperactivity disorder drug, after it was found to trigger Stevens-Johnson Syndrome (SJS), a serve allergic reaction that often times is fatal. The debilitating drug induced reaction kills thousands of consumers each year and was determined to be too great a risk for the public at large. Finally, the FDA is taking a firm stand on new drugs related to and triggering SJS. Now if they would help facilitate the removal of other dangerous drugs connected to SJS already on the market we all would be a lot safer when it comes to dealing with this tragic allergic reaction.
A partner with Childers, Schlueter & Smith, LLC,, Brandon Smith has devoted his practice to pharmaceutical litigation, mass torts, products liability and serious personal injury. A frequent guest speaker at legal seminars all over the country—Brandon is focused on helping injured victims nationwide, however possible. Named a SuperLawyer again in 2019, he has also been called out as one of 10 Best Attorneys For Georgia by the American Institute Of Personal Injury Attorneys and a Top 100 Lawyer in Georgia by the National Trial Lawyers in 2019.
Comments for this article are closed.